Sellas Life Sciences faces high risk in the Phase 3 REGAL AML trial for GPS. Click here to know why I rate the SLS stock a ...

Company to host analyst call at 5:00pm ET today to discuss progress to date and expansion of clinical trial SOUTH SAN ...

Detailed price information for Moleculin Biotech CS (MBRX-Q) from The Globe and Mail including charting and trades.

My client based in Cape Town (North) is currently looking for a AML Analyst to join them on an independent contract basis (12 months) Onsite / Hybrid work model The role is situated within the AML ...